Medications for Obesity

41 results

  • Adipex-p (phentermine hydrochloride)

    (Phentermine Hydrochloride)
    PD-Rx Pharmaceuticals Inc
    Usage: ADIPEX-P® is indicated as a short-term adjunct for weight reduction, combined with exercise, behavioral modification, and caloric restriction. It is for patients with a body mass index (BMI) of 30 kg/m² or ≥27 kg/m² with risk factors like controlled hypertension or diabetes.

  • Amphetamine sulfate (amphetamine sulfate)

    (Amphetamine Sulfate)
    Granules Pharmaceuticals Inc.
    Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity in conjunction with a comprehensive treatment program, and as a short-term adjunct for exogenous obesity in patients not responding to other weight loss strategies.

  • Amphetamine sulfate (amphetamine sulfate)

    (amphetamine sulfate)
    Bryant Ranch Prepack
    Usage: Amphetamine sulfate tablets are indicated for narcolepsy, attention deficit disorder with hyperactivity as part of a comprehensive treatment program, and short-term treatment of exogenous obesity alongside caloric restriction for patients not responding to other weight loss methods.

  • Amphetamine sulfate (amphetamine sulfate)

    (amphetamine sulfate)
    Lannett Company, Inc.
    Usage: Amphetamine sulfate tablets (5 mg and 10 mg) are indicated for narcolepsy, Attention Deficit-Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term management of exogenous obesity as an adjunct to a caloric restriction regimen in patients unresponsive to other therapies.

  • Appetite and weight with p.h.a.t. (adrenalinum, adrenocorticotrophin, agrimonia eupatoria, flos, anacardium orientale, antimonium crudum, calcarea carbonica, castanea sativa, flos, cortisone aceticum, fucus vesiculosus, hypothalamus, kali bichromicum, oleander, pituitarum posterium, sabadilla, staphysagria, thyroidinum)

    (Adrenalinum, Adrenocorticotrophin, Agrimonia eupatoria, flos, Anacardium orientale, Antimonium crudum, Calcarea carbonica, Castanea sativa, flos, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Oleander, Pituitarum posterium, Sabadilla, Staphysagria, Thyroidinum)
    King Bio Inc.
    Usage: The drug is indicated for managing symptoms related to obesity, including excessive appetite, cravings (especially for sweets and starches), overeating, water retention, ravenous hunger, and excess abdominal fat.

  • Benzphetamine hydrochloride (benzphetamine hydrochloride)

    (benzphetamine hydrochloride)
    PD-Rx Pharmaceuticals Inc
    Usage: Benzphetamine hydrochloride tablets are indicated for short-term management of exogenous obesity in patients with a BMI of 30 kg/m² or higher, who have not succeeded with diet and exercise alone. It is intended for use as monotherapy only. Risks should be considered.

  • Contrave

    (naltrexone hydrochloride and bupropion hydrochloride)
    Nalpropion Pharmaceuticals LLC
    Usage: CONTRAVE is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater (obese) or 27 kg/m² or greater (overweight) with weight-related comorbid conditions, as an adjunct to diet and exercise. Safety with other weight loss products is not established.

  • Diethylpropion hcl controlled-release (diethylpropion hydrochloride)

    (Diethylpropion hydrochloride)
    Rebel Distributors Corp
    Usage: Diethylpropion hydrochloride is indicated for short-term management of exogenous obesity in patients with a BMI of 30 kg/m² or higher who have not succeeded with diet and/or exercise alone. It serves as a monotherapy adjunct in a weight reduction regimen.

  • Diethylpropion hcl immediate-release (diethylpropion hydrochloride)

    (Diethylpropion hydrochloride)
    Keltman Pharmaceuticals Inc.
    Usage: Diethylpropion hydrochloride is indicated for the short-term management of exogenous obesity in patients with a body mass index (BMI) of 30 kg/m² or higher, who have not responded to diet and exercise alone. It should be used as monotherapy in conjunction with caloric restriction.

  • Diethylpropion hydrochloride (diethylpropion hydrochloride)

    (Diethylpropion Hydrochloride)
    Lannett Company, Inc.
    Usage: Diethylpropion hydrochloride extended-release tablets, 75 mg, are indicated for short-term management of exogenous obesity in patients with a BMI of 30 kg/m² or higher who have not responded to diet and exercise alone. It is intended for use as monotherapy.